Search results for: 'ME1A-01'
-
14 Jan 2019  |  North America  |  Market Research
Growth Opportunities in the Global qPCR and dPCR Market, Forecast to 2023
Novel Applications in Oncology and Applied Sciences, Growing Research and Diagnostic Use in Developing Regions, and Automated Modular Workflows to Drive Growth
Overview: PCR continues to be the gold standard for nucleic acid amplification by combining accuracy and efficacy that users across areas such as research, pharma & biotech, diagnostics as well as applied sciences depend upon. Such widespread usage continues to drive the industry, even protecting it to some extent from overall economic/market fluct...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Jun 2016  |  North America  |  Market Research
Growth Opportunities in the US Point-of-care Testing Market
Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics
The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and ...
$4,950.00
Special Price $3,712.50 save 25 %
-
21 Jul 2016  |  North America  |  Market Research
Strategic Analysis of the Global Medical Imaging Informatics Market
Evaluating Growth Patterns and Opportunities across the Imaging IT Solution Set
With new investment objectives, product segments, deployment models, business models, end-user bases, and stakeholder groups coming on board, the imaging informatics technology stack is continually expanding, both laterally and vertically. This research service is designed to provide an in-depth view into each one of the 4 product categories compri...
$3,500.00
Special Price $2,625.00 save 25 %
-
04 Jul 2016  |  North America  |  Market Research
The Global Immuno-oncology Therapeutics Market—Checkpoint Inhibitors
The Next Generation of Cancer Therapies
Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibi...
$8,000.00
Special Price $6,000.00 save 25 %
-
16 Aug 2016  |  North America  |  Market Research
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market
Emerging Business Models Drive Transformation
The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to comme...
$7,000.00
Special Price $5,250.00 save 25 %
-
31 Aug 2016  |  North America  |  Market Research
Analysis of the US Digital and Computed Radiography Equipment Market
A Current Market Assessment and Outlook Through 2020
As the oldest and most utilized medical imaging modality, diagnostic general X-ray imaging is a workhorse modality for any medical imaging provider and an anchor modality for any medical imaging equipment vendor. In the United States, the computed and digital radiography markets are on the brink of a new growth phase. New regulatory mandates, techn...
$4,950.00
Special Price $3,712.50 save 25 %
-
13 Sep 2016  |  North America  |  Market Research
US Next-generation Sequencing Services Market
$1,000 Genome Pricing and Throughput to Drive More and Larger Sequencing Projects
The next-generation sequencing (NGS) services market includes all sequencing services conducted with next-generation or third-generation platforms that use newer technology than traditional capillary electrophoresis (CE) sequencing. Services include project scoping, NGS sample preparation tasks (i.e., library prep and target enrichment), and NGS-ba...
$4,950.00
Special Price $3,712.50 save 25 %
-
15 Nov 2016  |  North America  |  Market Research
Healthcare 2020—Business Model Transformation Guidebook
Exploring New Models for Monetizing Services and Solutions
Healthcare as an industry is entering a phase of rapid transformation. Digitization of products, services, and commerce models are democratizing current healthcare systems and unlocking new values by displacing high-cost gatekeepers and previously inaccessible segments. Around 80% of the business models in 2025 will be driven by platform-based heal...
$4,950.00
Special Price $3,712.50 save 25 %
-
04 Nov 2016  |  North America  |  Market Research
Vision 2025 - The Future of Healthcare
Projecting Market Transformations and Growth Opportunities
Global healthcare trends of aging populations, rising chronic disease prevalence, and urbanization are bound to further strain healthcare systems already grappling with issues of healthcare access, quality, and cost. New treatment paradigms are required that integrate elements of prediction, prevention, and automation to make care more affordable a...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Nov 2016  |  North America  |  Market Research
The US Molecular Diagnostics Market, Forecast to 2021
Polymerase Chain Reaction (PCR) Holds Close to 53% Share but Strong Clinical Research will Push NGS to Revolutionize this Space in the Next 5 to 10 Ye
The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...
$4,950.00
Special Price $3,712.50 save 25 %